Repotrectinib effective in ROS1-fusion-positive NSCLC

Nature Reviews Clinical Oncology, Published online: 26 January 2024; doi:10.1038/s41571-024-00864-4Repotrectinib effective in ROS1-fusion-positive NSCLC

https://www.nature.com/articles/s41571-024-00864-4

Source: Nature Reviews Clinical Oncology - January 26, 2024 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research

More News: Cancer & Oncology | Non-Small Cell Lung Cancer